2022
DOI: 10.1007/s00103-022-03527-w
|View full text |Cite
|
Sign up to set email alerts
|

Instrumente behördlicher Kommunikation zu Anwendungsrisiken von Arzneimitteln

Abstract: ZusammenfassungDie aktive Kommunikation von Behörden, wie dem Bundesinstitut für Arzneimittel und Medizinprodukte (BfArM) und dem Paul-Ehrlich-Institut (PEI), einschließlich der Kontaktpflege zu Fachkreisen sowie Presse- und Öffentlichkeitsarbeit sind wesentliche Voraussetzung dafür, dass Informationen zu Anwendungsrisiken von Arzneimitteln sowohl betroffene Patientinnen und Patienten als auch Angehörige der Heilberufe schnell und gezielt erreichen. Die verschiedenen Instrumente der gezielten Kommunikation bes… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
1
1
1

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(1 citation statement)
references
References 2 publications
0
1
0
Order By: Relevance
“…To increase trust in the vaccination campaign and public health authorities, there is a need for transparent, timely, accessible, and understandable communication of information on various aspects related to COVID-19 vaccines, such as efficacy, safety, risks, and scientific uncertainties [ 66 68 ]. German health authorities such as the Paul Ehrlich Institute have used various tools such as safety reports or red letters to implement active risk communication [ 67 ]. It should be investigated to what extent these communication measures reach and are perceived as adequate by the medical staff, the population, and especially population groups with specific safety needs such as people with long COVID.…”
Section: Discussionmentioning
confidence: 99%
“…To increase trust in the vaccination campaign and public health authorities, there is a need for transparent, timely, accessible, and understandable communication of information on various aspects related to COVID-19 vaccines, such as efficacy, safety, risks, and scientific uncertainties [ 66 68 ]. German health authorities such as the Paul Ehrlich Institute have used various tools such as safety reports or red letters to implement active risk communication [ 67 ]. It should be investigated to what extent these communication measures reach and are perceived as adequate by the medical staff, the population, and especially population groups with specific safety needs such as people with long COVID.…”
Section: Discussionmentioning
confidence: 99%